SALIX PHARMACEUTICALS LTD Uncategorized Contracts & Agreements
31 Contracts & Agreements
- 8510 Colonnade CenterDrive, Raleigh, NC 27615 www.salix.com ###-###-#### F ###-###-#### (Filed With SEC on January 5, 2015)
- Salix Pharmaceuticals, Inc. 8510Colonnade Center Drive Raleigh, NC 27615 (Filed With SEC on November 7, 2014)
- COMMERCIALIZATION AGREEMENT (Filed With SEC on August 8, 2014)
- CREDITAGREEMENT, dated as of January 2, 2014, among SALIX PHARMACEUTICALS, LTD., asthe Borrower, THE LENDERS PARTY HERETO and JEFFERIES FINANCE LLC, as Administrative Agent and... (Filed With SEC on January 2, 2014)
- INDEMNITY AGREEMENT (Filed With SEC on December 23, 2013)
- INTRODUCTION (Filed With SEC on November 7, 2013)
- Portions of this exhibit marked [*] are omitted and arerequested to be treated confidentially. Salix Pharmaceuticals, Inc. 8510 Colonnade Center Drive Raleigh, North Carolina... (Filed With SEC on November 8, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. (Filed With SEC on February 28, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. (Filed With SEC on February 28, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. (Filed With SEC on February 28, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. (Filed With SEC on February 28, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. (Filed With SEC on February 28, 2012)
- Portions of this exhibit marked [*] are omitted and are requested to be treatedconfidentially. (Filed With SEC on February 28, 2012)
- Portions of this exhibit marked [*] are requested to be treated confidentially. (Filed With SEC on November 9, 2011)
- Portions of this exhibit marked [*] are requested to be treated confidentially. (Filed With SEC on November 9, 2011)
- Portions of this document marked [*] are requested to be treated confidentially. (Filed With SEC on May 10, 2011)
- RIFAXIMIN (Filed With SEC on November 9, 2009)
- Portions of the exhibit marked [*] are requested to be treated confidentially. Dated7 December 2005 (Filed With SEC on March 26, 2009)
- * Portions of this document marked [*] are requested to be treated confidentially. (Filed With SEC on March 11, 2009)
- * Portions of this document marked [*] are requested to be treated confidentially. (Filed With SEC on March 11, 2009)
- SALIX PHARMACEUTICALS, LTD. as Issuer AND U.S. BANK NATIONAL ASSOCIATION (Filed With SEC on August 22, 2008)
- $55,000,000 AGGREGATE PRINCIPAL AMOUNT Salix Pharmaceuticals, Ltd. (Filed With SEC on August 22, 2008)
- * Portions of this document marked [*] are requested to be treated confidentially. DATED MARCH 13, 2008 DR. FALK PHARMA GmbH -and- (Filed With SEC on May 7, 2008)
- Portions of this exhibit marked [*] are requested to be treatedconfidentially. CO-PROMOTION AGREEMENT (Filed With SEC on November 9, 2007)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. LICENSEAGREEMENT (Filed With SEC on July 5, 2006)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially Dated 7 December 2005 (Filed With SEC on December 13, 2005)
- Portions of this exhibit marked [*] are requested to be treated confidentially. (Filed With SEC on May 10, 2005)
- Portion of this exhibit marked [*] are omitted and are requested to be treated confidentially. (Filed With SEC on March 12, 2004)
- Portions of this exhibit marked [*] are omitted and are requested to be treated confidentially. DATED 24th OF NOVEMBER 2003 DR. FALK PHARMA GmbH - and - SALIX PHARMACEUTICALS,... (Filed With SEC on March 12, 2004)
- are requested to be treated confidentially. (Filed With SEC on November 14, 2003)
- Salix Pharmaceuticals, Ltd. (Filed With SEC on January 10, 2003)
